NCT02972567View on ClinicalTrials.gov

Evaluation of the Effects of a L.Reuteri Strain on Markers of Inflammation, Cardiovascular Risk and Fatty Liver Disease

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Metabolic Syndrome X
Interventions
DIETARY_SUPPLEMENT

Lactobacillus spp

9 log10 cfu/capsule. 1 capsule/day for 12 weeks

DIETARY_SUPPLEMENT

Control

Maltodextrin

Trial Locations (1)

23007

Complejo Hospitalario Universitario de Jaen, Jaén

All Listed Sponsors
collaborator

Universidad de Granada

OTHER

collaborator

Complejo Hospitalario de Jaen

UNKNOWN

lead

Biosearch S.A.

INDUSTRY

NCT02972567 - Evaluation of the Effects of a L.Reuteri Strain on Markers of Inflammation, Cardiovascular Risk and Fatty Liver Disease | Biotech Hunter | Biotech Hunter